POLYPLUS TRANSFECTION has a total of 25 patent applications. Its first patent ever was published in 2003. It filed its patents most often in EPO (European Patent Office), Canada and Republic of Korea. Its main competitors in its focus markets biotechnology, pharmaceuticals and macromolecular chemistry and polymers are INTERNA TECH B V, APTAMIR THERAPEUTICS INC and TECHULON INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | Canada | 4 | |
#3 | Republic of Korea | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 4 | |
#5 | China | 2 | |
#6 | Brazil | 1 | |
#7 | France | 1 | |
#8 | Israel | 1 | |
#9 | New Zealand | 1 | |
#10 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Macromolecular chemistry and polymers |
# | Name | Total Patents |
---|---|---|
#1 | Erbacher Patrick | 22 |
#2 | Stock Fabrice | 12 |
#3 | Lenne Nathalie | 7 |
#4 | Adib Abdennaji | 7 |
#5 | Toussaint Moreau Valérie | 4 |
#6 | Hafdi Nadia | 3 |
#7 | Fabrice Stock | 2 |
#8 | Philipson Yann | 2 |
#9 | Hellal Malik | 2 |
#10 | Abdennaji Adib | 2 |
Publication | Filing date | Title |
---|---|---|
WO2021023796A1 | Compositions for transfecting a nucleic acid molecule into a cell comprising heterocyclic compounds grafted to a cationic polymer, and their applications | |
EP3646854A1 | Compositions for transfecting mrna into a cell and their applications | |
EP2229445A2 | Means for delivery of nucleic acids active for gene silencing using synthetic polymers | |
EP2183297A2 | Method for manufacturing linear polyethylenimine (pei) for transfection purpose and linear pei obtained with such method | |
EP2075342A1 | Method for hybridizing nucleic acids | |
KR20090074689A | Compositions for transfection of oligonucleotides active for gene silencing and their biological and therapeutical applications | |
EP1888749A1 | Oligonucleotides for rna interference and biological applications thereof |